insights_auto
Por que TNDM caiu 5,47%?
Saiba maischevron_right
TNDM:NASDAQ
Tandem Diabetes Care Inc
US$ 17,47
arrow_downward
-5,47%(-1,01) 1D
17 de nov., 13:32:31 GMT-5 · USD
search
Todos os ativos
| Códigos | Preço | Variação | % de variação |
|---|
insights_autoGerando os principais insights para TNDM…
Abrir
US$ 18,25
Alta
US$ 18,64
Baixa
US$ 17,46
Valor de mercado
1,22 bi
Volume médio
2,57 mi
Volume
745,57 mil
Alto — 52 sem
US$ 29,65
Baixo — 52 sem
US$ 12,26
LPA
-US$ 0,72
Beta
1,59
Ações em circulação
69,79 mi
Nº de funcionários
2 mil
Abrir
US$ 18,25
Alta
US$ 18,64
Baixa
US$ 17,46
Valor de mercado
1,22 bi
Volume médio
2,57 mi
Volume
745,57 mil
Alto — 52 sem
US$ 29,65
Baixo — 52 sem
US$ 12,26
LPA
-US$ 0,72
Beta
1,59
Ações em circulação
69,79 mi
Nº de funcionários
2 mil
Notícias
De fontes da web e parceiros de notícias
ChartMill
·
há 57 minutos
Today's S&P 500 Top Movers: Reddit Leads Gainers, Salesforce Leads Decliners
MarketWatch
·
há 57 minutos
Why Salesforce’s stock is leading S&P 500 decliners amid tech jitters
24/7 Wall St.
·
há 31 minutos
Bill Ackman Cut His Microsoft Stake. Your S&P 500 Fund Can’t.
BigGo Finance
·
há 1 hora
Netflix Shares Trade Below S&P 500 Multiple After 35% Slide as Analysts See Upside
Perfil
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
Sobre Tandem Diabetes Care Inc
CEOJohn Sheridan
Funcionários2,5 mil
Data de fundaçãojan. 2006
Sede-
SetorHealth Care
Setor-